Spineart

SPINEART is a privately held healthcare startup, established in 2005 and headquartered in Switzerland. The company prides itself on its commitment to Quality, Innovation, and Simplicity. Specializing in spinal care, Spineart has made significant strides in accelerating technology adoption and setting a higher standard in the industry. With a global reach spanning over 60 markets, the company has introduced pioneering technologies in minimally invasive surgery, motion preservation, fusion, biologics, and fracture treatments. Its comprehensive portfolio encompasses traceable barcoded sterile-packed implants and compact instrument sets, promoting greater safety, cost-efficiency, and compliance for hospital systems worldwide. In recognition of its remarkable contributions to technological innovations, commercial activities, job creations, and ESG principles, Spineart was honored with the "Prix de l'Economie Genevoise 2022". This accolade underscores the company's dedication to excellence and its positive impact on the industry. The most recent significant development for Spineart is the Fr.20.00M Convertible Note investment made on 18 March 2024. This injection of capital is indicative of investor confidence in the company's mission and potential for growth. Overall, Spineart's commitment to challenging convention, delivering global expertise, and empowering superior care positions it as a compelling player in the healthcare sector, making it an intriguing prospect for potential investors and partners. To learn more about career opportunities with Spineart, visit https://www.spineart.com/careers/.